Home Cart Sign in  
Chemical Structure| 486-86-2 Chemical Structure| 486-86-2

Structure of N-Methylcytisine
CAS No.: 486-86-2

Chemical Structure| 486-86-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

N-Methylcytisine's nicotinic receptors have high affinity (KD = 50 nM)to nAChR from squid optical ganglia.

Synonyms: Caulophylline; N-Me-cy; BRN-0012448

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of N-Methylcytisine

CAS No. :486-86-2
Formula : C12H16N2O
M.W : 204.27
SMILES Code : O=C1C=CC=C2N1C[C@]3([H])CN(C)C[C@@]2([H])C3
Synonyms :
Caulophylline; N-Me-cy; BRN-0012448
MDL No. :MFCD00211091

Safety of N-Methylcytisine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
DPX2 cells 10 µM 24 hours To evaluate the effect of N-Methylcytisine on PXR activation. Results showed that N-Methylcytisine significantly activated PXR, with luciferase activity increasing ∼10-fold. Drug Metab Dispos. 2010 Dec;38(12):2226-31
SMMC-7721 cells 4 mg/mL 24 hours To evaluate the inhibitory effect of N-Methylcytisine on the proliferation of SMMC-7721 cells. The results showed that N-Methylcytisine significantly inhibited the proliferation of SMMC-7721 cells. Sci Rep. 2018 Jan 12;8(1):624
HepaRG cells 10 µM 48 hours To evaluate the effect of N-Methylcytisine on CYP3A4 expression. Results showed that N-Methylcytisine significantly induced CYP3A4 mRNA expression, and this induction was suppressed by the PXR antagonist sulforaphane. Drug Metab Dispos. 2010 Dec;38(12):2226-31

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
ICR mice DSS-induced colitis model Oral 1, 4, 16 mg/kg Once daily for 7 days To evaluate the protective effect of NMC on DSS-induced colitis and its possible mechanisms. Results demonstrated that NMC significantly attenuated DSS-induced clinical symptoms and pathological damage, reduced myeloperoxidase activity and pro-inflammatory cytokine levels, and blocked NF-κB activation by inhibiting IκB and IKK phosphorylation. Molecules. 2018 Feb 25;23(3):510
DBA/1 mice Collagen-induced arthritis (CIA) model Oral 100.0 mg/kg Once daily for 30 days To evaluate the anti-inflammatory effects of N-Methylcytisine in CIA mice, results showed that different batches of CRM extracts significantly suppressed the levels of pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-17. Molecules. 2017 Oct 26;22(11):1826

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.90mL

0.98mL

0.49mL

24.48mL

4.90mL

2.45mL

48.95mL

9.79mL

4.90mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories